Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy

Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy

Bibliographic Details
Main Authors:	Ali Kermani, Reza Bagheri, Hessam Taheri, Mohsen Aliakbarian, Ehsan Soltani, Mona Joudi
Format:	Article
Language:	English
Published:	Termedia Publishing House 2020-01-01
Series:	Polish Journal of Thoracic and Cardiovascular Surgery
Subjects:	esophageal cancer survival recurrence pattern neoadjuvant chemoradiotherapy
Online Access:	https://www.termedia.pl/Evaluation-of-survival-and-recurrence-patterns-in-esophageal-cancer-patients-with-pathological-response-to-neoadjuvant-chemoradiotherapy,40,39479,1,1.html

Similar Items

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
by: Hui‐Jiang Gao, et al.
Published: (2020-09-01)

Predictive Value of Endoscopic Observations and Biopsy After Neoadjuvant Chemoradiotherapy in Assessing the Pathologic Complete Response of Patients With Esophageal Squamous Cell Carcinoma
by: Ali Taghizadeh Kermani, et al.
Published: (2022-05-01)

The Comparative Effect of Definitive Chemoradiotherapy and Neoadjuvant Chemoradiotherapy Plus Surgery on One-Year Survival Rate of Esophageal Cancer Patients
by: Fatemeh Khanaki, et al.
Published: (2022-12-01)

Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma
by: Fei Chen, et al.
Published: (2022-08-01)

Effect of circumferential resection margin status on survival and recurrence in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
by: Yi-Min Gu, et al.
Published: (2022-09-01)

A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
by: Ding T, et al.
Published: (2021-10-01)

Preliminary study on involving field irradiation radiotherapy in neoadjuvant chemoradiotherapy for esophageal cancer
by: DONG Xiaohuan, LIU Jun, LI Hongxuan, CHENG Yan, LI Yue, YU Wen, CAI Xuwei, FU Xiaolong
Published: (2023-03-01)

Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
by: Wing-Keen Yap, et al.
Published: (2022-11-01)

MR radiomics predicts pathological complete response of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a multicenter study
by: Yunsong Liu, et al.
Published: (2024-01-01)

Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
by: Guihong Liu, et al.
Published: (2024-03-01)

Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer
by: Akiyuki Wakita, et al.
Published: (2023-11-01)

Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
by: Lei Xu, et al.
Published: (2022-11-01)

Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery
by: Qingtao Qiu, et al.
Published: (2020-08-01)

A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
by: Kazem Anvari, et al.
Published: (2015-01-01)

Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study)
by: Hai-Yu Zhou, et al.
Published: (2020-07-01)

Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
by: Magnus Nilsson, et al.
Published: (2022-07-01)

Gross Tumor Volume Predicts Survival and Pathological Complete Response of Locally Advanced Esophageal Cancer After Neoadjuvant Chemoradiotherapy
by: Rong Wang, et al.
Published: (2022-06-01)

Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
by: Jinsong Yang, et al.
Published: (2023-03-01)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
by: Weiming Han, et al.
Published: (2022-11-01)

Study of neoadjuvant chemoradiotherapy with combined S-1 and low-dose cisplatin for patients with clinical stage II/III esophageal cancer
by: Kodai Takahashi, et al.
Published: (2018-03-01)

Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
by: Jaehyeon Park, et al.
Published: (2021-11-01)

Recurrence timing and patterns incorporating lymph node status after neoadjuvant chemoradiotherapy plus esophagectomy for esophageal squamous cell carcinoma
by: Guihong Liu, et al.
Published: (2024-03-01)

The Key Clinical Questions of Neoadjuvant Chemoradiotherapy for Resectable Esophageal Cancer—A Review
by: Dan Han, et al.
Published: (2022-07-01)

Sex differences in cancer-specific survival for locally advanced esophageal cancer after neoadjuvant chemoradiotherapy: A population-based analysis
by: Jiaqiang Wang, et al.
Published: (2022-07-01)

Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer
by: Han Gyul Yoon, et al.
Published: (2020-04-01)

Influence of Chemoradiotherapy Strategies and Factors on the Five-Years Survival of Patients with Esophageal Cancer
by: Seyed Kazem Mirinezhad, et al.
Published: (2014-08-01)

Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
by: Wenwu He, et al.
Published: (2022-06-01)

Predictive value of neutrophil-lymphocyte ratio in preoperative neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
by: XIONG Kai, et al.
Published: (2021-01-01)

Surgical outcomes of neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in patients of locally advanced carcinoma of esophagus: A prospective cross-sectional comparative study
by: Rohit Kumar Jha, et al.
Published: (2024-02-01)

History and current situation of neoadjuvant treatment for locally advanced esophageal cancer
by: Junyi Li, et al.
Published: (2021-09-01)

PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
by: Matteo Fassan, et al.
Published: (2019-10-01)

Prognostic Effect of the Dose of Radiation Therapy and Extent of Lymphadenectomy in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma
by: Chu-Pin Pai, et al.
Published: (2022-08-01)

Neoadjuvant Therapy for Locally Advanced Esophageal Cancers
by: Runkai Huang, et al.
Published: (2022-04-01)

Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinomaResearch in context
by: Jing Wen, et al.
Published: (2022-12-01)

Advantages of nasogastric tube feeding during neoadjuvant concurrent chemoradiotherapy for esophageal cancer: A retrospective study
by: Jie Dong, et al.
Published: (2023-06-01)

Change in Maximal Esophageal Wall Thickness Provides Prediction of Survival and Recurrence in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy and Surgery
by: Wu Y, et al.
Published: (2021-03-01)

Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study
by: Zhao J, et al.
Published: (2023-08-01)

Neoadjuvant chemoradiotherapy for resectable esophageal cancer: an in-depth study of randomized controlled trials and literature review
by: Xiao-Feng Duan, et al.
Published: (2014-09-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis
by: Yusuke Sato, et al.
Published: (2021-02-01)